Chord Energy shares rise as crude oil spikes above $100, boosting cash-flow expectations

Chord Energy (CHRD) is up 3.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is a sharp jump in crude oil prices, which tends to lift U.S. oil producers on expectations for stronger near-term revenue and free cash flow. CHRD also recently reiterated its 2026 plan and shareholder-return framework, which can amplify upside moves when commodity prices rise.

Details:

Global crude benchmarks surged and traded above $100 per barrel amid escalating Middle East supply and shipping disruption concerns, raising the market’s implied oil-price deck for producers.

As a Williston Basin-focused E&P, Chord’s earnings and free cash flow are highly sensitive to changes in WTI, so a sudden oil spike can quickly translate into higher expected cash generation and buyback/dividend capacity.

In its Feb. 25, 2026 update, the company issued 2026 outlook commentary and highlighted a strategy focused on capital discipline and maximizing free cash flow rather than chasing oil-growth.

The company also declared a $1.30 per share base dividend payable March 27, 2026, with a March 12, 2026 record date, which may have supported incremental demand for the stock.

Sources:

Associated Press, Axios, Chord Energy Investor Relations

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CHRD Insider Trading Activity

$CHRD insiders have traded $CHRD stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CHRD stock by insiders over the last 6 months:

LARA J KROLL (SVP & Chief Accounting Officer) sold 5,000 shares for an estimated $568,300
SHANNON BROWNING KINNEY (EVP, CAO, GC & Corp Secretary) sold 1,801 shares for an estimated $205,962
SAMANTHA HOLROYD purchased 1,250 shares for an estimated $106,875

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CHRD Hedge Fund Activity

We have seen 172 institutional investors add shares of $CHRD stock to their portfolio, and 312 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BOSTON PARTNERS removed 1,815,287 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $180,385,069
VICTORY CAPITAL MANAGEMENT INC removed 1,164,878 shares (-36.8%) from their portfolio in Q4 2025, for an estimated $107,984,190
AMERICAN CENTURY COMPANIES INC added 630,620 shares (+51.3%) to their portfolio in Q4 2025, for an estimated $58,458,474
DIMENSIONAL FUND ADVISORS LP added 561,899 shares (+85.6%) to their portfolio in Q4 2025, for an estimated $52,088,037
AQR CAPITAL MANAGEMENT LLC removed 498,486 shares (-52.8%) from their portfolio in Q4 2025, for an estimated $46,209,652
FMR LLC added 429,813 shares (+6.8%) to their portfolio in Q4 2025, for an estimated $39,843,665
PACER ADVISORS, INC. removed 428,716 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $39,741,973

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CHRD Congressional Stock Trading

Members of Congress have traded $CHRD stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CHRD stock by members of Congress over the last 6 months:

REPRESENTATIVE MICHAEL GUEST sold up to $15,000 on 01/09.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 01/09.
REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CHRD Analyst Ratings

Wall Street analysts have issued reports on $CHRD in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 01/28/2026
UBS issued a "Buy" rating on 01/09/2026
Mizuho issued a "Outperform" rating on 12/12/2025
William Blair issued a "Outperform" rating on 11/21/2025
Wells Fargo issued a "Overweight" rating on 11/14/2025
Roth Capital issued a "Buy" rating on 10/14/2025
RBC Capital issued a "Outperform" rating on 10/07/2025

To track analyst ratings and price targets for $CHRD, check out Quiver Quantitative's $CHRD forecast page.

$CHRD Price Targets

Multiple analysts have issued price targets for $CHRD recently. We have seen 11 analysts offer price targets for $CHRD in the last 6 months, with a median target of $123.0.

Here are some recent targets:

Paul Diamond from Citigroup set a target price of $120.0 on 03/06/2026
Mark Lear from Piper Sandler set a target price of $158.0 on 03/05/2026
Josh Silverstein from UBS set a target price of $142.0 on 03/05/2026
Hanwen Chang from Wells Fargo set a target price of $109.0 on 01/27/2026
Devin McDermott from Morgan Stanley set a target price of $114.0 on 01/23/2026
Scott Hanold from RBC Capital set a target price of $128.0 on 01/13/2026
Nitin Kumar from Mizuho set a target price of $150.0 on 12/12/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.